Your browser doesn't support javascript.
loading
A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial.
Andermann, Tessa M; Fouladi, Farnaz; Tamburini, Fiona B; Sahaf, Bita; Tkachenko, Ekaterina; Greene, Courtney; Buckley, Matthew T; Brooks, Erin F; Hedlin, Haley; Arai, Sally; Mackall, Crystal L; Miklos, David; Negrin, Robert S; Fodor, Anthony A; Rezvani, Andrew R; Bhatt, Ami S.
Afiliação
  • Andermann TM; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Fouladi F; Department of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, North Carolina.
  • Tamburini FB; Department of Genetics, Department of Medicine, Stanford University, Stanford, California.
  • Sahaf B; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California.
  • Tkachenko E; Stanford University School of Medicine, Stanford University, Stanford, California.
  • Greene C; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California.
  • Buckley MT; Department of Genetics, Department of Medicine, Stanford University, Stanford, California.
  • Brooks EF; Division of Hematology, Department of Medicine, Stanford University, Stanford, California.
  • Hedlin H; Quantitative Sciences Unit, Department of Medicine, Stanford University, Stanford, California.
  • Arai S; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California.
  • Mackall CL; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California.
  • Miklos D; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California.
  • Negrin RS; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California.
  • Fodor AA; Department of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, North Carolina. Electronic address: arezvani@stanford.edu.
  • Rezvani AR; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California. Electronic address: asbhatt@stanford.edu.
  • Bhatt AS; Department of Genetics, Department of Medicine, Stanford University, Stanford, California; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California. Electronic address: afodor@uncc.edu.
Transplant Cell Ther ; 27(11): 932.e1-932.e11, 2021 11.
Article em En | MEDLINE | ID: mdl-34274493
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Microbioma Gastrointestinal / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Microbioma Gastrointestinal / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2021 Tipo de documento: Article